Antitrust Antitrust

Generic drug association lacks standing to challenge California pay-for-delay law, appeals court says

By Khushita Vasant
  • 24 Jul 2020 17:22
  • 24 Jul 2020 17:22
The Association for Accessible Medicines lacks standing to challenge California's law that bars pay-for-delay agreements, a federal appeals court ruled today.
In an order Friday, a three-judge panel on the US Court of Appeals for the Ninth Circuit not only affirmed a decision denying the group's request for a preliminary

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Khushita Vasant

Chief Antitrust Correspondent, US

Khushita covers US antitrust enforcement and litigation for MLex. A former Brussels hand, she wrote about about antitrust & mergers for the Policy and Regulatory Report (PaRR), she has covered the EU's actions against Google, Apple, Facebook and Amazon to name a few. Khushita specialises in tech and patent policy coverage which featured in the Concurrences Antitrust Writing Awards. Previously as a financial journalist for The Wall Street Journal and Dow Jones Newswires, she wrote about monetary policy and the bond and currency markets. Khushita studied journalism at Mumbai University, and received an Erasmus Mundus scholarship for a masters from universities in Germany and Austria.

Discover MLex

Stay on top of global regulatory developments

Latest News